Scotiabank Raises Price Target on Janux Therapeutics to $62 From $42, Keeps Sector Perform Rating
Scotiabank Raises Price Target on Janux Therapeutics to $62 From $42, Keeps Sector Perform Rating
加拿大丰业银行将Janux Therapeutics的目标股价从42美元上调至62美元,并保持板块表现评级
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册